{"id":"W2322956806","doi":"10.1097/01.cot.0000292093.23682.2a","title":"Use of Pemetrexed (Alimta) for NSCLC Gets ODAC Recommendation for Accelerated, Although Not Full, Approval","year":2004,"lang":"en","type":"article","venue":"Oncology Times","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pemetrexed; Medicine; Docetaxel; Clinical trial; Lung cancer; Oncology; Internal medicine; Approved drug; Drug; Cancer; Pharmacology; Cisplatin; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005155285,0.0001827698,0.0006877767,0.0002082112,0.0001265803,0.00004237431,0.0001780914,0.0002819418,0.0002737147],"category_scores_gemma":[0.0004322245,0.0002168323,0.0002050452,0.00009808887,0.00009454175,0.0005837657,0.00003048336,0.0001036865,0.00008239167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003691423,"about_ca_system_score_gemma":0.0001802157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000259513,"about_ca_topic_score_gemma":0.0001762906,"domain_scores_codex":[0.9983645,0.00001167867,0.0008052788,0.0004136184,0.00001641972,0.0003884903],"domain_scores_gemma":[0.9985398,0.0002904686,0.0007542381,0.0002164592,0.0001173407,0.00008170119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004395459,0.001278264,0.001841785,0.0002959461,0.0006316223,0.000003024761,0.001566991,0.002383466,0.001357981,0.5310143,0.1595962,0.2956349],"study_design_scores_gemma":[0.004105527,0.001229944,0.001033034,0.00001465025,0.0000283997,0.000003179261,0.00004632212,0.001465045,0.002632276,0.02252277,0.9666066,0.0003123158],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4131642,0.003312751,0.4032564,0.06244776,0.008291787,0.008393371,0.009087379,0.0003262246,0.09172018],"genre_scores_gemma":[0.8122665,0.001238744,0.1665973,0.006564686,0.001426712,0.001014439,0.0008392842,0.0001620403,0.009890319],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8070103,"threshold_uncertainty_score":0.8842166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1357765585655567,"score_gpt":0.3200303274830376,"score_spread":0.1842537689174808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}